Offer - Urjas Oil for just ₹ 1
Jakavi 15 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Primary Myelofibrosis. Secondary and off-label uses of Jakavi 15 Tablet have also been mentioned below.
The correct dosage of Jakavi 15 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Jakavi 15 Tablet include Bruising or discoloration, Weight gain. Besides the aforementioned side effects, there are other adverse effects of Jakavi 15 Tablet as well, which are listed below. These side effects of Jakavi 15 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Jakavi 15 Tablet's effect during pregnancy is Unknown and Unknown while nursing. Further, the section on Jakavi 15 Tablet related warnings talks about Jakavi 15 Tablet's effects on the liver, heart and kidney.
Jakavi 15 Tablet is contraindicated in people with pre-existing medical conditions like Drug Allergy, Anemia as it can result in adverse effects. Other contraindications of Jakavi 15 Tablet have been discussed in the sections ahead.
Besides this, Jakavi 15 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Jakavi 15 Tablet is considered safe while driving, and is addictive.
Jakavi 15 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Jakavi 15 Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Jakavi 15 Tablet safe for pregnant women?
No research has been done to ascertain the safety of Jakavi in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Jakavi 15 Tablet safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Jakavi for breastfeeding women are not known.
What is the effect of Jakavi 15 Tablet on the Kidneys?
Jakavi can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Jakavi 15 Tablet on the Liver?
There may be an adverse effect on the liver after taking Jakavi. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Jakavi 15 Tablet on the Heart?
Jakavi may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Jakavi 15 Tablet unless your doctor advises you to do so -
Is this Jakavi 15 Tablet habit forming or addictive?
Forming a habit of Jakavi 15 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Jakavi 15 Tablet does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but consume Jakavi 15 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Jakavi 15 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Jakavi 15 Tablet
There isn't any research available on the side effects of taking Jakavi 15 Tablet with food.
Interaction between Alcohol and Jakavi 15 Tablet
Information about the interaction of Jakavi 15 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Jakafi™ (ruxolitinib)
